Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1987-10-21
pubmed:abstractText
The intracavitary delivery of biological agents is based on sound pharmacologic, immunologic, and physiologic rationales. Results of early-stage clinical trials have confirmed both an advantage for exposure of the body cavity to the biologicals as compared with that of the systemic circulation following intracavitary drug delivery, as well as the suggestion of definite clinical utility. Trials that are in progress and those planned for the future will hopefully define optimal drug combinations, concentrations, and treatment schedules. Ultimately, randomized controlled trials will be required to define a role for such therapy as compared with standard therapeutic approaches to diseases principally confined to body cavities.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-6580
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
404-11
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Intracavitary administration of biological agents.
pubmed:publicationType
Journal Article